Published • loading... • Updated
Light-Controlled Gene Expression Platform Reportedly Doubles Standard Fed-Batch Manufacturing Performance
Prolific Machines, an Emeryville, CA-based biotech company focusing on light-controllable biomanufacturing powered by optogenetics, reported a productivity milestone of 21 g/L in a 15-day intensified fed-batch CHO run for a monoclonal antibody (mAb). This is more than double the industry standard of below 10 g/L, and the company is on track to reach its goal of 25 g/L in fed-batch by the end of 2026, according to company officials. Prolific’s li…
1 Articles
1 Articles
Light-Controlled Gene Expression Platform Reportedly Doubles Standard Fed-Batch Manufacturing Performance
Prolific Machines, an Emeryville, CA-based biotech company focusing on light-controllable biomanufacturing powered by optogenetics, reported a productivity milestone of 21 g/L in a 15-day intensified fed-batch CHO run for a monoclonal antibody (mAb). This is more than double the industry standard of below 10 g/L, and the company is on track to reach its goal of 25 g/L in fed-batch by the end of 2026, according to company officials. Prolific’s li…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
